APA (7th ed.) Citation

Sheng, Y., Teng, S., Wang, J., Wang, H., & Tse, A. N. (2024). Tumor growth inhibition‐overall survival modeling in non‐small cell lung cancer: A case study from GEMSTONE‐302. CPT: Pharmacometrics & Systems Pharmacology, 13(3), 437. https://doi.org/10.1002/psp4.13094

Chicago Style (17th ed.) Citation

Sheng, Yucheng, Shu‐wen Teng, Jingru Wang, Hao Wang, and Archie N. Tse. "Tumor Growth Inhibition‐overall Survival Modeling in Non‐small Cell Lung Cancer: A Case Study from GEMSTONE‐302." CPT: Pharmacometrics & Systems Pharmacology 13, no. 3 (2024): 437. https://doi.org/10.1002/psp4.13094.

MLA (9th ed.) Citation

Sheng, Yucheng, et al. "Tumor Growth Inhibition‐overall Survival Modeling in Non‐small Cell Lung Cancer: A Case Study from GEMSTONE‐302." CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 3, 2024, p. 437, https://doi.org/10.1002/psp4.13094.